Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
The Resilience Alliance
NCT02521571 · View on ClinicalTrials.gov ↗
Study Summary
The Resilience Alliance is a skill-based staff development intervention for child protective staff that focuses on improving job satisfaction, resilience, optimism and social support, while decreasing attrition, stress reactivity and burnout. The investigators believe that the intervention will enhance the capacity of child welfare workers to care for themselves, which will result in them providing better care for the children and families involved with the child welfare system. The Resiliance Alliance will be implemented in two child protective offices, Manhattan Zone C and Brooklyn Zone B. Staff from two additional offices (Staten Island Zone A and Brooklyn Zone C) will serve as a control group. A web-based survey will be administered in the group receiving the Resiliance Alliance intervention prior to intervention, at completion of the intervention, and 3 months post completion. The control group will be given a two-part training (3 hours in total) on secondary traumatic stress. The control group will then be asked to complete the same survey as the intervention group.
Conditions Studied
Interventions
- BEHAVIORAL Resiliance Alliance
- BEHAVIORAL Secondary traumatic stress training
Study Locations (4)
New York
- Brooklyn ACS Borough Office — Brooklyn
- Manhattan ACS Borough Office — New York
- Staten Island ACS Borough Office — Staten Island
- Bronx ACS Borough Office — The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 357 participants |
| Start Date | 2011-12 |
| Est. Completion | 2012-07 |
| Phase | NA |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02521571
The ClinicalTrials.gov registry entry for NCT02521571 describes a study currently listed as completed. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 357 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,204 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 1 condition, with Secondary Traumatic Stress appearing as the primary indexed condition, and to 2 interventions — of which Resiliance Alliance is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT02521571 reports 4 study locations spanning 1 distinct geographic area — top geographies include New York. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT02521571 about?
NCT02521571 is a clinical study titled "The Resilience Alliance". The Resilience Alliance is a skill-based staff development intervention for child protective staff that focuses on improving job satisfaction, resilience, optimism and social support, while decreasing attrition, stress reactivity and burnout. The investigators believe that the intervention will enha...
What is the current status of trial NCT02521571?
This trial is currently completed. It is a NA study. The enrollment target is 357 participants. The study started on 2011-12. Estimated completion is 2012-07.
What conditions does trial NCT02521571 study?
This clinical trial studies the following conditions: Secondary Traumatic Stress. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT02521571?
The interventions under investigation include: Resiliance Alliance (BEHAVIORAL), Secondary traumatic stress training (BEHAVIORAL). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT02521571?
This trial is sponsored by NYU Langone Health, which has 1,204 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT02521571 being conducted?
This trial has 4 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.